General Information of This Metabolic Reaction (MR) (ID:
MR000999) |
Formula |
|
Reactant |
Exemestane |
Product |
17beta-dihydroexemestane |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 1A2 (CYP1A2)
|
DME Info
|
Lauric acid omega-hydroxylase (CYP4A11)
|
DME Info
|
Aldo-keto reductases (AKR)
|
DME Info
|
Metabolic Type
|
Reduction
-
Reduction
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17beta-dihydroexemestane. Pharmacol Res Perspect. 2017 Apr 27;5(3):e00314.
|
2 |
LABEL:EXEMESTANE tablet
|
3 |
Inhibition of the aromatase enzyme by exemestane cysteine conjugates. Mol Pharmacol. 2022 Aug 11;102(5):216-22. doi: 10.1124/molpharm.122.000545.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.